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In the title compound, H3O
+ C8H7O8P2
 , the anions form
inversion dimmers by way of pairs of O—H   O hydrogen
bonds involving the phosphonic functions and via the hydro-
nium cation. Further O—H   O links involving the hydro-
nium cation play a prominant part in the cohesion of the
crystal structure by building bridges between bisphosphonate
pairs, forming inﬁnite ribbons along the b-axis direction and
by cross-linking these ribbons perpendicularly along the a-axis
direction, forming an inﬁnite three-dimensional hydrogen-
bond network. The benzene ring and the C O atoms of the
furan ring are disordered over two sets of positions of equal
occupancy.
Related literature
For the pharmacological applications of bisphosphonates, see
Heymann et al. (2004); Rodan & Martin (2000); Fournier et al.
(2002); Hamma-Kourbali et al. (2003); Wood et al. (2002);
Martin et al. (2001, 2002); Sanders et al. (2003). For general
background, see Lecouvey et al. (2003a,b); Monteil et al.
(2005); Gue ´nin et al. (2004); Lecouvey & Leroux (2000);
Vachal et al. (2006). For related structures, see Sylvestre et al.
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Table 1
Hydrogen-bond geometry (A ˚ ,  ).
D—H   AD —H H   AD    AD —H   A
O11—H11   O23
i 0.82 1.69 2.504 (3) 168
O12—H12   O22
ii 0.82 1.64 2.438 (3) 164
O21—H21   O13
iii 0.82 1.72 2.522 (3) 167
O1W—H1W   O13 0.94 2.09 2.996 (4) 162
O1W—H2W   O23
iv 0.95 1.90 2.845 (4) 174
O1W—H3W   O2B
v 0.94 1.93 2.875 (10) 177
O1W—H3W   O2A
v 0.94 1.95 2.853 (9) 159
Symmetry codes: (i)  x þ 3
2; y þ 1
2; z þ 1; (ii)  x þ 3
2;y   1
2; z þ 1
2; (iii) x;y þ 1;z;
(iv) x; y;z   1
2; (v)  x þ 2; y; z þ 1.
Data collection: COLLECT (Hooft, 1998); cell reﬁnement: HKL
(Otwinowski & Minor, 1997); data reduction: HKL; program(s) used
to solve structure: SHELXS97 (Sheldrick, 2008); program(s) used to
reﬁne structure: SHELXL97 (Sheldrick, 2008); molecular graphics:
ORTEP-3 for Windows (Farrugia, 1997); software used to prepare
material for publication: WinGX (Farrugia, 1999) and CrystalBuilder
(Welter, 2006).
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Hydronium (3-oxo-1-phosphono-1,3-dihydroisobenzofuran-1-yl)phosphonate
C. Barbey, P. Retailleau, E. Guénin and N. Dupont
Comment
The title compound, C8H8O8P2, belongs to the bisphosphonate family (or 1-hydroxymethylene-1,1-bisphosphonic acids or
HMBPs). These compounds are synthetic structural analogues of pyrophosphate and are characterized by an enzymatically
stable P—C—P group instead of the P—O—P. They are known to have a wide range of applications. They are clinically
used in treatement of various bone diseases, such as Pagets disease, osteoporosis, tumor osteolysis or hypercalcemia of
malignancy (Heymann et al., 2004; Rodan & Martin, 2000). They are known to induce inhibition of breast and prostate
cancer cell proliferation and more recently to inhibit angiogenesis in vitro and in vivo (Fournier et al., 2002; Hamma-Kourbali
et al., 2003; Wood et al., 2002). In addition, HMBPs have also activity against several trypanosomatid and apicomplexan
parasites (Martin et al., 2001; Martin et al., 2002; Sanders et al., 2003). HMBPs are usually obtained from two different
synthetic methods (Lecouvey & Leroux, 2000). Unfortunately, these methods are not always suitable for fragile, aromatic
or functionalized substrates. Recently we developed a new method of HMBP synthesis from silylated phosphite and acid
chlorides (Lecouvey et al., 2003a,b; Monteil et al., 2005) (or acid anhydrides (Guénin et al., 2004)) that gave an easy
access to the obtaining of aromatic and functionalized HMBPs. Using phthalic anhydride as a substrate, a new and original
cyclic bisphosphonate was described (Guénin et al., 2004). The cyclic structure of this compound was provided indirectly
by IR measurements and further opening of the cycle in basic media. Here we undoubtly proved this cyclic structure, the
hydroxy function being part of a lactone. This compound presents a real biological interest as it could act as a prodrug. The
hydroxy function which is essential to the HMBP biological properties is in this particular case totally hidden, but could be
reformed in the cell by esterase activity. Such acyloxymethyl bis(phosphonate) prodrugs have already been described and
the protection shown to be reversible (Vachal et al., 2006).
Bisphosphonate are compounds with super-acid properties, and they easily crystallize as mono salts of sodium or potassi-
um (Sylvestre et al., 2001) or as well characterized solvates (Lecouvey et al., 2002) where crystals generally include water.
The asymetric unit of the title compound is built up from one deprotonated HMBP anion and a H3O+ cation (Fig. 1)
which are linked through OW—H···O hydrogen bonds (Table 1). The crystal structure consists of hydrophilic layers that
enclose the hydronium cation and bisphosphonate function where molecules linked by pair and less hydrophilic layers made
of aromatic rings attached to the cyclic bisphosphonate structure.
Experimental
Synthesis of (3-Oxo-1-phosphono-1,3-dihydro-isobenzofuran-1-yl) -phosphonic acid] was done according to the published
procedure (Guénin et al., 2004, compound 3 h). Briefly two equivalents of tris(trimethylsilyl)phosphite were added under
N2 to phtalic anhydride in freshly distilled THF at room temperature. The resulting mixture was then heated at 50°C for 12
h. After evaopration of volatile fractions methanol was added to the residue. After 1 h stirring and methanol evaporation
the title compound was washed several times with dimethyl ether. Crystallization was done by slow evaporation at roomsupplementary materials
sup-2
temperature from a concentrated methanol/ water (9/1) solution to give colorless crystal with max. size 0.3 mm, suitable
for diffraction.
Refinement
All H atoms attached to C or O atoms were fixed geometrically and treated as riding with C—H = 0.93 Å (aromatic) or
0.96 Å (methylene) and O—H = 0.82 Å (hydoxyl) with Uiso(H) = 1.2Ueq(C) (aromatic) and 1.5Ueq(O) for others. Owing
to the fact that each of the P2—O22 and P2—O23 bonds seems to be a mixture of single and double bonds and that solvent
molecule was 3 times hydrogen donor, the solvent molecule was refined as H3O+ and the bisphoshonate as the basic form. H
atoms of the hydronium were located in difference Fourier syntheses and initially refined using restraints (O-H= 0.93 (1)Å)
with Uiso(H) = 1.5Ueq(O). In the last stage of refinement they were treated as riding on the parent O atom.
Disorder of the cyclic structure was modeled with two different positions per disordered atom with occupation factors of
0.5. The two disordered part were refined using the tools, PART and SAME, available in SHELXL-97 (Sheldrick, 2008).
Figures
Fig. 1. Molecular View of the title compound. Displacement ellipsoids are drawn at the 30%




– F000 = 1280
Mr = 312.10 Dx = 1.716 Mg m−3
Monoclinic, C2/c
Mo Kα radiation
λ = 0.71069 Å
Hall symbol: -C 2yc Cell parameters from 2338 reflections
a = 26.2271 (9) Å θ = 0.4–25.4º
b = 7.2913 (3) Å µ = 0.40 mm−1
c = 15.2621 (6) Å T = 293 (2) K
β = 124.103 (2)º Parallelepipedic, colourless





2139 independent reflectionssupplementary materials
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Radiation source: fine-focus sealed tube 1627 reflections with I > 2σ(I)
Monochromator: graphite Rint = 0.071
Detector resolution: 9 pixels mm-1 θmax = 25.4º
T = 293(2) K θmin = 3.0º
φ and ω scans h = −31→30
Absorption correction: none k = −8→8
14205 measured reflections l = −18→17
Refinement
Refinement on F2 Secondary atom site location: difference Fourier map
Least-squares matrix: full Hydrogen site location: inferred from neighbouring
sites
R[F2 > 2σ(F2)] = 0.045 H-atom parameters constrained
wR(F2) = 0.126
  w = 1/[σ2(Fo
2) + (0.0625P)2 + 4.0148P]
where P = (Fo
2 + 2Fc
2)/3
S = 1.05 (Δ/σ)max = 0.001
2139 reflections Δρmax = 0.33 e Å−3
229 parameters Δρmin = −0.37 e Å−3
21 restraints Extinction correction: none
Primary atom site location: structure-invariant direct
methods
Special details
Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The
cell esds are taken into account individually in the estimation of esds in distances, angles and torsion angles; correlations between esds
in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell esds is used
for estimating esds involving l.s. planes.
Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F2, convention-
al R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > σ(F2) is used only for calculating R-
factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 are statistically about twice as large
as those based on F, and R- factors based on ALL data will be even larger.
Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2)
x y z Uiso*/Ueq Occ. (<1)
P1 0.81092 (4) 0.03803 (12) 0.41201 (6) 0.0268 (3)
O11 0.79680 (10) −0.0117 (3) 0.49420 (18) 0.0338 (6)
H11 0.7615 0.0191 0.4721 0.051*
O12 0.75192 (9) 0.0932 (3) 0.30772 (17) 0.0338 (6)
H12 0.7528 0.0541 0.2582 0.051*
O13 0.84830 (10) −0.1086 (3) 0.40406 (18) 0.0339 (6)
P2 0.82143 (3) 0.45428 (11) 0.46825 (6) 0.0250 (3)
O23 0.80619 (9) 0.4158 (3) 0.54732 (17) 0.0316 (5)
O22 0.76507 (9) 0.5004 (3) 0.36019 (17) 0.0323 (6)supplementary materials
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O21 0.87289 (10) 0.5997 (3) 0.50941 (18) 0.0339 (6)
H21 0.8605 0.6856 0.4676 0.051*
C1 0.85893 (13) 0.2462 (4) 0.4606 (2) 0.0252 (7)
O1 0.90991 (9) 0.2067 (3) 0.57008 (15) 0.0329 (6)
C2A 0.9660 (4) 0.2436 (17) 0.5830 (7) 0.030 (3) 0.50
O2A 1.0134 (4) 0.2317 (14) 0.6679 (7) 0.058 (3) 0.50
C3A 0.9536 (4) 0.2866 (17) 0.4802 (7) 0.032 (3) 0.50
C4 0.89030 (14) 0.2748 (5) 0.4041 (2) 0.0295 (7)
C5 0.86705 (16) 0.3115 (5) 0.2986 (3) 0.0373 (8)
H5 0.8250 0.3067 0.2467 0.045*
C6A 0.9093 (5) 0.356 (2) 0.2737 (11) 0.037 (4) 0.50
H6A 0.8947 0.3890 0.2046 0.045* 0.50
C7A 0.9732 (6) 0.3515 (19) 0.3495 (10) 0.056 (4) 0.50
H7A 1.0003 0.3736 0.3296 0.068* 0.50
C8A 0.9952 (5) 0.3150 (15) 0.4523 (9) 0.050 (3) 0.50
H8A 1.0374 0.3092 0.5032 0.060* 0.50
C2B 0.9639 (5) 0.1751 (16) 0.5743 (9) 0.038 (4) 0.50
O2B 1.0105 (4) 0.1345 (12) 0.6576 (8) 0.053 (2) 0.50
C3B 0.9517 (4) 0.2220 (17) 0.4728 (8) 0.030 (3) 0.50
C6B 0.9075 (6) 0.297 (3) 0.2668 (12) 0.045 (5) 0.50
H6B 0.8922 0.3094 0.1955 0.055* 0.50
C7B 0.9703 (6) 0.264 (2) 0.3393 (11) 0.062 (5) 0.50
H7B 0.9971 0.2723 0.3177 0.074* 0.50
C8B 0.9926 (5) 0.2211 (16) 0.4419 (10) 0.052 (3) 0.50
H8B 1.0339 0.1918 0.4897 0.062* 0.50
O1W 0.85750 (13) −0.1636 (4) 0.2188 (2) 0.0646 (9)
H1W 0.8473 −0.1639 0.2690 0.097*
H2W 0.8410 −0.2545 0.1654 0.097*
H3W 0.9009 −0.1544 0.2575 0.097*
Atomic displacement parameters (Å2)
U11 U22 U33 U12 U13 U23
P1 0.0238 (4) 0.0260 (5) 0.0315 (5) 0.0011 (3) 0.0160 (4) 0.0003 (3)
O11 0.0267 (12) 0.0395 (14) 0.0395 (13) 0.0046 (10) 0.0212 (11) 0.0068 (11)
O12 0.0250 (11) 0.0408 (14) 0.0277 (11) 0.0002 (10) 0.0099 (10) −0.0051 (10)
O13 0.0351 (12) 0.0286 (13) 0.0461 (14) 0.0040 (10) 0.0277 (12) −0.0010 (10)
P2 0.0219 (4) 0.0269 (5) 0.0268 (4) −0.0013 (3) 0.0141 (4) 0.0004 (3)
O23 0.0298 (11) 0.0380 (13) 0.0329 (12) 0.0034 (10) 0.0211 (11) 0.0044 (10)
O22 0.0224 (11) 0.0385 (14) 0.0311 (12) 0.0041 (10) 0.0120 (10) 0.0051 (10)
O21 0.0259 (11) 0.0296 (13) 0.0391 (13) −0.0050 (10) 0.0138 (11) 0.0014 (10)
C1 0.0174 (14) 0.0338 (18) 0.0203 (14) 0.0011 (13) 0.0081 (13) 0.0012 (12)
O1 0.0210 (11) 0.0494 (15) 0.0257 (11) 0.0043 (10) 0.0116 (10) 0.0059 (10)
C2A 0.012 (4) 0.046 (9) 0.026 (5) 0.000 (4) 0.007 (4) −0.008 (4)
O2A 0.022 (4) 0.111 (8) 0.032 (4) −0.004 (5) 0.009 (3) −0.001 (5)
C3A 0.024 (4) 0.033 (9) 0.038 (5) −0.008 (4) 0.016 (4) −0.005 (4)
C4 0.0237 (16) 0.0341 (19) 0.0338 (16) 0.0004 (14) 0.0180 (15) 0.0002 (14)
C5 0.0329 (18) 0.046 (2) 0.0331 (18) 0.0081 (16) 0.0186 (16) 0.0073 (16)supplementary materials
sup-5
C6A 0.046 (6) 0.032 (11) 0.039 (5) 0.008 (5) 0.027 (5) 0.006 (5)
C7A 0.050 (6) 0.086 (12) 0.057 (6) −0.004 (7) 0.045 (6) 0.005 (7)
C8A 0.032 (5) 0.074 (9) 0.048 (5) −0.016 (6) 0.026 (4) −0.010 (6)
C2B 0.033 (6) 0.035 (8) 0.043 (6) −0.005 (4) 0.019 (5) −0.010 (5)
O2B 0.020 (3) 0.083 (7) 0.038 (4) 0.008 (4) 0.005 (3) −0.002 (5)
C3B 0.024 (4) 0.028 (8) 0.039 (5) −0.006 (4) 0.019 (4) −0.009 (4)
C6B 0.073 (8) 0.036 (12) 0.053 (7) 0.017 (6) 0.051 (7) 0.014 (6)
C7B 0.050 (7) 0.091 (12) 0.070 (8) 0.011 (7) 0.049 (7) 0.024 (8)
C8B 0.029 (5) 0.074 (9) 0.061 (6) −0.001 (6) 0.030 (5) 0.007 (7)
O1W 0.0470 (16) 0.081 (2) 0.0599 (18) 0.0001 (16) 0.0266 (15) −0.0147 (16)
Geometric parameters (Å, °)
P1—O13 1.501 (2) C4—C3B 1.395 (9)
P1—O12 1.526 (2) C5—C6A 1.397 (11)
P1—O11 1.537 (2) C5—C6B 1.397 (11)
P1—C1 1.842 (3) C5—H5 0.9300
O11—H11 0.8200 C6A—C7A 1.405 (11)
O12—H12 0.8200 C6A—H6A 0.9300
P2—O23 1.495 (2) C7A—C8A 1.360 (11)
P2—O22 1.511 (2) C7A—H7A 0.9300
P2—O21 1.546 (2) C8A—H8A 0.9300
P2—C1 1.847 (3) C2B—O2B 1.207 (10)
O21—H21 0.8200 C2B—C3B 1.437 (11)
C1—O1 1.469 (3) C3B—C8B 1.393 (10)
C1—C4 1.503 (4) C6B—C7B 1.396 (12)
O1—C2A 1.397 (9) C6B—H6B 0.9300
O1—C2B 1.399 (10) C7B—C8B 1.366 (11)
C2A—O2A 1.193 (9) C7B—H7B 0.9300
C2A—C3A 1.447 (10) C8B—H8B 0.9300
C3A—C8A 1.390 (10) O1W—H1W 0.9423
C3A—C4 1.397 (9) O1W—H2W 0.9469
C4—C5 1.391 (4) O1W—H3W 0.9450
O13—P1—O12 115.47 (13) C3A—C4—C1 108.0 (5)
O13—P1—O11 111.42 (13) C4—C5—C6A 117.4 (6)
O12—P1—O11 110.24 (12) C4—C5—C6B 117.6 (7)
O13—P1—C1 106.83 (13) C6A—C5—C6B 18.0 (14)
O12—P1—C1 105.50 (13) C4—C5—H5 121.3
O11—P1—C1 106.80 (13) C6A—C5—H5 121.3
P1—O11—H11 109.5 C6B—C5—H5 118.0
P1—O12—H12 109.5 C5—C6A—C7A 122.2 (10)
O23—P2—O22 112.47 (12) C5—C6A—H6A 118.9
O23—P2—O21 111.60 (13) C7A—C6A—H6A 118.9
O22—P2—O21 112.81 (13) C8A—C7A—C6A 119.5 (11)
O23—P2—C1 106.84 (13) C8A—C7A—H7A 120.3
O22—P2—C1 110.08 (13) C6A—C7A—H7A 120.3
O21—P2—C1 102.39 (13) C7A—C8A—C3A 119.0 (10)
P2—O21—H21 109.5 C7A—C8A—H8A 120.5
O1—C1—C4 103.8 (2) C3A—C8A—H8A 120.5supplementary materials
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O1—C1—P1 106.1 (2) O2B—C2B—O1 119.4 (10)
C4—C1—P1 110.7 (2) O2B—C2B—C3B 132.5 (10)
O1—C1—P2 105.48 (18) O1—C2B—C3B 107.6 (8)
C4—C1—P2 113.9 (2) C8B—C3B—C4 122.0 (8)
P1—C1—P2 115.74 (15) C8B—C3B—C2B 128.0 (9)
C2A—O1—C2B 21.1 (7) C4—C3B—C2B 110.0 (7)
C2A—O1—C1 109.7 (4) C7B—C6B—C5 121.7 (11)
C2B—O1—C1 109.7 (5) C7B—C6B—H6B 119.2
O2A—C2A—O1 120.8 (9) C5—C6B—H6B 119.2
O2A—C2A—C3A 131.1 (9) C8B—C7B—C6B 120.3 (11)
O1—C2A—C3A 108.1 (7) C8B—C7B—H7B 119.9
C8A—C3A—C4 121.7 (8) C6B—C7B—H7B 119.9
C8A—C3A—C2A 128.8 (9) C7B—C8B—C3B 118.1 (10)
C4—C3A—C2A 109.1 (7) C7B—C8B—H8B 120.9
C5—C4—C3B 119.7 (5) C3B—C8B—H8B 120.9
C5—C4—C3A 119.7 (5) H1W—O1W—H2W 119.8
C3B—C4—C3A 19.8 (8) H1W—O1W—H3W 106.4
C5—C4—C1 131.7 (3) H2W—O1W—H3W 113.4
C3B—C4—C1 107.6 (5)
Hydrogen-bond geometry (Å, °)
D—H···A D—H H···A D···A D—H···A
O11—H11···O23i 0.82 1.69 2.504 (3) 168
O12—H12···O22ii 0.82 1.64 2.438 (3) 164
O21—H21···O13iii 0.82 1.72 2.522 (3) 167
O1W—H1W···O13 0.94 2.09 2.996 (4) 162
O1W—H2W···O23iv 0.95 1.90 2.845 (4) 174
O1W—H3W···O2Bv 0.94 1.93 2.875 (10) 177
O1W—H3W···O2Av 0.94 1.95 2.853 (9) 159
Symmetry codes: (i) −x+3/2, −y+1/2, −z+1; (ii) −x+3/2, y−1/2, −z+1/2; (iii) x, y+1, z; (iv) x, −y, z−1/2; (v) −x+2, −y, −z+1.supplementary materials
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Fig. 1